Business
OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries
BELLEVUE, WA / ACCESS Newswire / January 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced the official closing of its acquisition of Woori IO, the reaffirmation of long-term equity alignment by Woori IO's historical shareholders, and the ...
About this update from Osr Holdings, Inc.
[{"type":"text","content":"BELLEVUE, WA / ACCESS Newswire / January 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced the official closing of its acquisition of Woori IO, the reaffirmation of long-term equity alignment by Woori IO's historical shareholders, and the initiation of a strategic review regarding a potential combination of its medical device subsidiaries.","length":355,"tagName":"p"},{"type":"text","content":"Woori IO Acquisition Closed","length":27,"tagName":"p"},{"type":"text","content":"OSRH confirmed that the previously announced acquisition of Woori IO and the related share exchange transaction have been formally completed in Korea, effective January 26, 2026. As a result, Woori IO is now a consolidated subsidiary of OSRH, further strengthening the Company's medical device and digital health platform, particularly in noninvasive glucose monitoring and wearable health technologies.","length":407,"tagName":"p"},{"type":"text","content":"Three-Year Equity Alignment Secured by Legacy Shareholder","length":57,"tagName":"p"},{"type":"text","content":"In connection with the closing, historical shareholders of Woori IO reaffirmed a three-year equity alignment framework, under which they have agreed to exchange their equity interests in OSR Holdings Co., Ltd. (OSRK) into NASDAQ-listed OSRH common stock only at a reference price of USD $10.00 per share. This voluntary structure is designed to prevent near-term dilution and align legacy shareholders with the long-term performance of OSRH's public equity, reflecting confidence in the Company's strategic direction and capital markets positioning.","length":557,"tagName":"p"},{"type":"text","content":"Strategic Review of Medical Device Subsidiaries","length":47,"tagName":"p"},{"type":"text","content":"Separately, Peter Hwang, CEO of OSRH, indicated that the Company is conducting a strategic review of a potential combination of its two medical device subsidiaries, Woori IO and RMC, with the goal of forming a new, integrated medical technology and distribution company.","length":270,"tagName":"p"},{"type":"text","content":"The review reflects the complementary strengths of the two businesses, including Woori IO's digital health and wearable-device capabilities, supported by collaboration initiatives with Samsung Electronics, along with RMC's established hospital network i...